共 120 条
[1]
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]
Ferlay J(2005)Comparison of breast cancer mortality in five countries: France, Italy, Japan, the UK and the USA from the WHO mortality database (1960–2000) Jpn J Clin Oncol 35 758-759
[3]
Soerjomataram I(2016)Past trends and future estimation of annual breast cancer incidence in Osaka, Japan Asian Pac J Cancer Prev 17 2847-2852
[4]
Siegel RL(2009)Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study Am J Epidemiol 169 1251-1259
[5]
Torre LA(2015)Mechanisms of hormonal therapy resistance in breast cancer Int J Clin Oncol 20 262-267
[6]
Jemal A(2014)ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) Ann Oncol 25 1871-1888
[7]
Kawamura T(2018)Recent advances in the treatment of breast cancer Front Oncol 8 227-529
[8]
Sobue T(2012)Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer N Engl J Med 366 520-e953
[9]
Toyoda Y(2018)CDK4/6 inhibition in breast cancer: current practice and future directions Ther Adv Med Oncol 10 1758835918786451-107
[10]
Tabuchi T(2018)CDK4/6 inhibitors in combination with hormone therapy for HR(+)/HER2() advanced breast cancer: a systematic review and meta-analysis of randomized controlled trials Clin Breast Cancer 18 e943-4429